Clinical Trial Detail

NCT ID NCT02488759
Title A Study to Investigate the Safety and Efficacy of Nivolumab in Virus-associated Tumors (CheckMate358)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Bristol-Myers Squibb
Indications

gastroesophageal junction adenocarcinoma

vaginal cancer

cervical cancer

Merkel cell carcinoma

stomach carcinoma

nasopharynx carcinoma

vulva carcinoma

head and neck cancer

Therapies

Nivolumab

Age Groups: adult

No variant requirements are available.